Global Liver Disease Diagnostics Market Insights, Forecast to 2029

Global Liver Disease Diagnostics Market Insights, Forecast to 2029

The global Liver Disease Diagnostics market is projected to grow from US$ 13,361.64 million in 2023 to US$ 20,102.98 million by 2029, at a Compound Annual Growth Rate (CAGR) of 7.05% during the forecast period.

North America Liver Disease Diagnostics market size is valued at US$ 5,019.20 million in 2022, while Asia Pacific and Europe Liver Disease Diagnostics are US$ 3,036.97 million and US$ 3,690.05 million, severally. The proportion of the North America is 40.95% in 2022, while APAC and Europe are 24.78% and 30.11% respectively, and it is predicted that APAC proportion will reach 28.57% in 2029, trailing a CAGR of 8.99% through the analysis period. China, Japan, South Korea, and India are noteworthy markets in APAC. As for the Europe Liver Disease Diagnostics landscape, Germany is projected to reach US$ 1,292.90 million by 2029 trailing a CAGR of 6.06% during 2023-2029.

The global key companies of Liver Disease Diagnostics include Roche, Abbott, Thermo Fisher Scientific, Siemens Healthineers, GE Healthcare, Canon Medical Systems, LabCorp, BD, Philips Healthcare and Randox Laboratories is the leading manufacturer in global Liver Disease Diagnostics market. The top 10 listed companies accounted for 39.41% of the market share in 2022 in terms of revenue.

Report Includes

This report presents an overview of global market for Liver Disease Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Liver Disease Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Liver Disease Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liver Disease Diagnostics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Liver Disease Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Liver Disease Diagnostics revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Abbott, Roche, Thermo Fisher Scientific, Randox Diagnostic Centers, Boston Scientific Corporation, LabCorp, Fujifilm Corporation, Horiba Medical, and Siemens Healthineers, etc.

By Company

Abbott

Roche

Thermo Fisher Scientific

Randox Laboratories

Boston Scientific

LabCorp

Fujifilm Corporation

Siemens Healthineers

BD

Cook Medical

GE Healthcare

Philips Healthcare

Canon Medical Systems

Qiagen

Segment by Type

Imaging Tests

Blood Tests

Biopsy

Segment by Application

Hospitals and Clinics

Diagnostic Centers

Others

By Region

North America

United States

Canada

Mexico

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Europe

Germany

France

U.K.

Italy

Switzerland

Rest of Europe

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

Saudi Arabia

UAE

Israel

Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Liver Disease Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Liver Disease Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by Type, by Application and by country, revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, revenue for each segment.

Chapter 8: Asia Pacific by Type, by Application and by country, revenue for each segment.

Chapter 9: Latin America by Type, by Application and by region, revenue for each segment.

Chapter 10: Middle East & Africa by Type, by Application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liver Disease Diagnostics revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

Show more